Background: Infection complicating a plastic-surgery procedure can be a catastrophic event, both for the patient and the surgeon. Surveys published in 1975 and 1985 demonstrated the "usual and customary" practices S c i e n t i f i c F o r u m I nfection complicating a plastic surgery procedure can be a catastrophic event. Even a minor infection can be discomfiting to both patient and surgeon. In today's litigious society, a postoperative wound infection is often interpreted as a preventable error. Although infection rates for most plastic surgery procedures, like those for other clean operations, are quite low (<5%), efforts to eliminate postoperative infections are constant. In an attempt to further reduce what some have already called an "irreducible minimum," prophylactic or preventive usage of antibiotics is steadily increasing. 1, 2 In 1975 and 1985, Krizek and colleagues 3, 4 surveyed board-certified plastic surgeons with regard to their use of prophylactic antibiotics. These surveys revealed that plastic surgeons increasingly used antibiotics under a wider variety of circumstances. 4 This increase occurred even though no evidence existed to indicate that such use of prophylactic antibiotics would decrease the rate of postoperative infection.
I
nfection complicating a plastic surgery procedure can be a catastrophic event. Even a minor infection can be discomfiting to both patient and surgeon. In today's litigious society, a postoperative wound infection is often interpreted as a preventable error. Although infection rates for most plastic surgery procedures, like those for other clean operations, are quite low (<5%), efforts to eliminate postoperative infections are constant. In an attempt to further reduce what some have already called an "irreducible minimum," prophylactic or preventive usage of antibiotics is steadily increasing. 1, 2 In 1975 and 1985, Krizek and colleagues 3, 4 surveyed board-certified plastic surgeons with regard to their use of prophylactic antibiotics. These surveys revealed that plastic surgeons increasingly used antibiotics under a wider variety of circumstances. 4 This increase occurred even though no evidence existed to indicate that such use of prophylactic antibiotics would decrease the rate of postoperative infection.
Data on the use of prophylactic antibiotics by plastic surgeons since 1985 are not available. An article by Baran et al, 5 on a randomized clinical trial conducted by plastic surgeons in Turkey and involving 1400 patients, did not report a statistically significant decrease in infection rates with a prophylactic sulbactam-ampicillin combination. However, data from trials of prophylactic antibiotics in two types of clean operations (inguinal herniorrhaphy and miscellaneous breast procedures) suggested that prophylactic antibiotics could reduce infection rates in procedures with inherently low incidences of infection. 6 These findings appeared to validate the statement made in the discussions of the previous two surveys of plastic surgeons: "The administration of an antibacterial agent at the proper time and in sufficient quantity to be therapeutically active should, theoretically, be uniformly effective in preventing or treating infection from susceptible organisms. Further, the expansion of coverage achieved by broad spectrum antibacterial agents should provide patients and surgeons with a blanket of protection against infection." 3, 4 The scope of plastic surgery procedures has changed significantly since the last antibiotic survey. The balance between aesthetic and reconstructive procedures has shifted for most plastic surgeons, and the type and breadth of aesthetic procedures have dramatically increased. Although guidelines for prophylactic antibiotic usage frequently appear, these tend to focus on cleancontaminated or contaminated cases. 7, 8 Aesthetic surgery procedures, and most plastic surgery procedures, are generally clean cases, with a few being classified as cleancontaminated. Uniformly agreed-upon guidelines for antibiotic usage do not exist in these cases, although a recently published survey of American Society of Plastic Surgeons (ASPS) members showed widespread use of antibiotics for 10 aesthetic procedures. 9 However, the authors found little or no correlation between reported clinical practice and the literature. We therefore thought it might be useful to review the current usage of prophylactic antibacterials by today's plastic surgeons. Such data, collected in a manner similar to that used in the two previous surveys, could then be used to evaluate trends of prophylactic antibiotic usage by plastic surgeons in the United States.
Methods
A survey of active ASPS members was conducted as a one-time mailing to determine the frequency of prophylactic antibacterial use, the timing of such administration, and the modifying factors that influence the decision to use such agents. The design of the questionnaire was nearly identical to that reported by Krizek et al in 1985 . 4 Respondents were asked about their use of perioperative prophylactic antibacterials in several categories of operations, including aesthetic and reconstructive procedures. For this study, prophylactic (or preventive) antibiotics were defined as those antibacterials "administered systemically in the absence of infection for the purpose of preventing infection." 3, 4 For the sake of completeness, a question about topical irrigation of the wound with antibacterial solution was included. Although no effort was made to identify the respondents, the character of their practices, or any outcome from the use or nonuse of antibiotics, a question was included to elicit the number of years respondents had been in practice.
The questionnaire elicited information concerning a variety of procedures performed by plastic surgeons in which antibacterial agents might be used. Most of these procedures were aesthetic in nature. Other categories included breast reconstruction, burns, congenital anomalies, craniomaxillofacial surgery, hand surgery, head and neck surgery, and a miscellaneous category including skin grafts and flaps. For each procedure or operation, the respondent was asked to check the frequency with which prophylactic antibiotics were used; answering (a) always (95%-100% of the time), (b) often (more than half of the time), (c) seldom (less than half of the time), or (d) never (0%-5% of the time). Respondents were asked to skip the question if they had not performed the procedure at least once in the preceding 5 years.
The next portion of the questionnaire dealt with the timing of the beginning of the administration of antibacterial agents. The choices were (a) before the operation, (b) during the operation, and (c) after the operation. Modifying factors that might influence a respondent to use prophylactic antibiotics for a procedure in which he or she otherwise would not be inclined to use them were evaluated. These factors included artificial heart valves, remote infection, administration of immunosuppressive drugs or steroids, diabetes mellitus, previous radiation in the operative field, obesity, and age.
As in the two previous surveys, the responses "always" and "often" were grouped together to determine the percentage of respondents using prophylactic antibiotics more than 50% of the time for a given procedure. 3, 4 Likewise, the responses "seldom" and "never" were grouped together to determine the number of respondents using prophylactic antibiotics less than 50% of the time for a specific operation. To determine the increase or decrease in the use of prophylactic antibiotics by plastic surgeons, we compared the results from this questionnaire with the results published in 1985 using r 2 analysis. 4 
Results
Respondents returned 1804 questionnaires, for a response rate of 35%. Although no one answered every question, the highest percentage of answers was for aesthetic procedures. Answers were completed by more than 95% of the respondents for blepharoplasty, rhytidectomy, abdominoplasty, suction-assisted lipoplasty, breast augmentation, and breast reduction. The highest response rate for nonaesthetic procedures was 92.3%, for local skin excisions of the head and neck area.
Compared with the findings of the 1985 survey, prophylactic antibacterial use increased in all procedures except inpatient management of burns, in which usage steadily decreased from 1975 to 1985 to 2000. These results were statistically significant in all cases (r 2 analy-sis, P = .001). Nearly half of the questions showed at least a doubling (100% increase) in "always" and "often" responses. Aesthetic procedures were most frequently in this group (Table 1) . In 7 operations, at least a 200% increase (tripling) over 1985 results was exhibited. These included rhinoplasty, blepharoplasty, rhytidectomy, and arm contouring ( Table 1 ). The only reconstructive procedures that showed such an increase were congenital and elective hand surgery and parotidectomy. However, for these procedures, the response rate for frequent antibiotic usage was still under 50%.
Prophylactic antibiotics were begun before surgery in 82% of instances. Modifying factors did not affect the decision to use prophylactic antibiotics as much as they did in the 1985 or 1975 surveys; only the use of antibiotics in the presence of an artificial heart valve was greater in 2000 than in the earlier studies (Table 2) . Antibacterial irrigation was used routinely, at least in some procedures, by 44% of the respondents. When analyzed on the basis of number of years in practice, we found that respondents who had been in practice for more than 20 years were statistically significantly less likely to use prophylactic antibiotics (P < .01).
Discussion
The widespread use of antimicrobial agents for prophylaxis has altered surgical practice markedly in the past 30 years and now represents one of the most frequent uses of antibiotics in hospitals, accounting for as much as half of all antibiotic usage. 2 Despite progress in the understanding of the principles of infection and the initiation of prophylactic antibiotics, the postoperative wound infection rate remains nearly the same as that of four decades ago. 7 The use of prophylactic antibiotics by plastic surgeons has been steadily increasing since 1975. 3, 4, 9 This trend is confirmed by our present study. One wonders why it continues; a review of the literature does not support the use of prophylactic antibiotics for many of the procedures performed by plastic surgeons.
The usefulness of antibiotic prophylaxis in clean-contaminated and contaminated surgery is now largely accepted. 10 For clean operations, most standards recommend prophylactic antibacterials only in procedures that include the implantation of permanent prosthetic materials. 2, 8, 10 Most plastic surgery procedures, especially aesthetic operations, are classified as clean. The infection rate in clean operations is quite low. In the largest prospective study of surgical wounds, Cruse et al 11 reported a 1.8% wound infection rate in clean proce- 
Classification by discipline revealed a 1.2% infection rate for clean plastic surgery operations and a 2.8% rate of postoperative wound infection for plastic surgery overall. Hopkins 12 has stated, "The established wisdom has been that antibiotics should not be used in clean surgery when the risk of infection is low, except when implanted prosthetic materials are used."
One confusing factor in determining indications for antibacterial prophylaxis for plastic surgical procedures is the prolonged operating time for many of the procedures. Haley et al 13 demonstrated that in operations lasting longer than 2 hours, the patient was at increased risk of postoperative wound infection. 13 This risk factor -identified in a group of 58,498 patients and tested in another 59,352 -held true regardless of wound classification. Therefore clean plastic surgery operations lasting longer than 2 hours are at increased risk of wound infection. Confusion arises because established, published guidelines for the use of prophylactic antibiotics do not state that a clean operation of more than 2 hours is an indication without other risk factors. 8, 10 Also, Polk et al 7 have suggested that in operations lasting more than 2 hours, antibiotic prophylaxis is less effective.
Proponents of prophylactic antibiotics for operations carrying a low risk of infection point to a 1990 article by Platt et al 6 in which the authors state that overall infection rates after clean procedures such as herniorraphy and breast surgery decreased by 48% in patients treated with prophylactic antibiotics. 6 Closer perusal of their data reveals that the rate of postoperative wound infection was decreased in breast procedures from 8.5% to 5.6 % and in herniorraphies from 1.9% to 1.3%. The conclusions from these data have been severely criticized because of the small sample size and because of an inherent bias caused by overestimating the incidence of infection. 14 A similar prospectively randomized double-blind study found that the use of prophylactic antibiotics in mammary operations did not reduce the incidence of postoperative wound infections. 15 One of the major problems in trying to determine the efficacy of prophylactic antibiotics is that most of the carefully designed trials that have been reported have included too few patients to be statistically convincing. The major determinants of a study's power are the number of infections that occur and the magnitude of the difference between treatments. 16 Approximately 65 infections are required to have an 80% chance (power) of finding a 50% reduction in infection rate if two equalsized groups of patients are studied. If the overall risk of infection is 5%, one must study approximately 1300 patients. Kaiser 17 has stated, "In studying the superiority of a different antibiotic regimen, randomization of approximately 900 patients would be necessary before a 50% reduction in the infection rate could be demonstrated at the P = 0.05 level. Many more patients would need to be studied to demonstrate reliably that differences did not exist-ie, to avoid a Type II error." Despite the difficulty of compiling reliable data from relatively small-scale studies, several clinical trials have investigated the use of prophylactic antibiotics to reduce postoperative wound infections in plastic surgery. Amland et al 18 performed a randomized double-blind placebo-controlled studyazithromycin given to 171 patients and placebo to 168 -and found a reduction in infections from 20.5% to 5.1% in antibiotic-treated patients. However, 1 year later the same group, reporting on another series of patients, concluded that no statistically significant difference existed in postoperative infection rates, regardless of the use of prophylactic antibiotics. 19 In an adequately sized study of 1400 patients, Baran et al 5 found no significant difference in postoperative infection rates between prophylactic antibiotic-and placebotreated groups across the gamut of plastic surgery operations. 5 In a related study of postoperative infection after skin surgery (not specifically plastic surgery) comprising 2165 patients, Bencini et al 20 reported a statistically significant reduction in 3 prophylactic antibiotic groups compared with placebo. The placebo-treated group had an infection rate of just 4.3% infection rate, and the longer the course of antibiotic treatment, up to 4 days, the lower the infection rate. It is noteworthy that these data counter the consensus in the literature. 21 Given the difficulty of interpreting the reported data, the steadily increasing use of prophylactic antibiotics in plastic surgery seen from 1975 to 1985 to the present is not surprising. However, no data appear to explain the increase of 100% to 200% in the use of antibiotics in aesthetic surgical procedures revealed in our survey. Perlotti et al 9 recently surveyed plastic surgeons with regard to 10 aesthetic procedures and found that most In our survey, antibiotic administration was begun before surgery in 82% of cases, compared with 81% in 1985 and 63% in 1975. Certainly the timing is evidencebased, with all major references recommending a preoperative start for prophylactic antibiotics. 2, 7, 8, 10 We found little change with regard to whether modifying factors influenced surgeons' decisions to use antibiotics in the updated survey. In fact, such factors as age, obesity, and radiation seemed somewhat less important. This may reflect a more sophisticated knowledge among plastic surgeons in 2000; no details were given with regard to degree of the factors. It is notable that the presence of a heart valve carried increased importance (Table 2) ; recent data indicate that skin surgery does not cause significant bacteremia. 25 One can only guess why surgeons in practice more than 20 years tend to use prophylactic antibiotics less frequently than do younger colleagues. We surmise that, as shown by the 1975 and 1985 surveys, plastic surgeons used antibacterial prophylaxis less often 20 years ago, when this group began practice, and they have found no compelling reason to change.
Given that no absolute data support or refute the use of prophylactic antibiotics, what harm can be caused by using them? Adverse effects were enumerated by the authors of the 1975 and 1985 surveys. They include allergic and idiosyncratic reactions to drugs; unbalanced ecology of patients, hospitals, and the environment; and the possibility that heretofore nonpathogenic organisms would become serious potential pathogens. 3, 4 Additional problems include gastrointestinal upset, thrombophlebitis, interference with the inflammatory events of early wound healing, development of resistant strains of bacteria, and the development of Candida difficile enterocolitis. 9 Finally there is the pharmacoeconomic question. Cost/benefit ratios have been determined for antimicrobial prophylaxis in several categories of surgery. 26, 27 Unfortunately, these studies have not been conducted for plastic surgery operations, particularly aesthetic procedures. McGowan 27 has stated that systematic economic analysis is necessary to determine the relative cost and benefit of prophylactic antibiotic usage. 27 
Conclusion
It is clear that the increased use of prophylactic antibiotics is not totally evidence-based. It is also clear that the statistical needs required means that the necessary evidence may not be forthcoming. Although it seems logical that prophylactic antibiotics should decrease infection rates because bacteria cause infections and antibiotics kill bacteria, data confirming this supposition in clinical practice are difficult to produce. Without such data, plastic surgeons continue to follow their own brand of logic. As mentioned in the 1975 and 1985 surveys, possible legal consequences play a major role in a plastic surgeon's decision whether to use prophylactic antibiotics. This comment was also prevalent in the responses to the survey by Perrotti et al. 9 As in the 1975 and 1985 surveys, the design of this study and the nature of the data available allow no conclusion to be drawn regarding the scientific propriety of decisions to use or not use antibacterials or the efficacy of their use in preventing infection. The responses to the questionnaire do seem to be a fair reflection of the patterns of prophylactic antibiotic usage among the responding plastic surgeons and to provide some documentation of what is "usual and customary." In no way does the information gained from the survey purport to imply what the "standard of care" should be. However, comparison with data reported in a similar manner in 1975 and 1985 does yield a meaningful picture of plastic surgeons' evolving use of prophylactic antibiotics over a 25-year period.■
